Alpha Tau Medical Ltd
DRTS | NASDAQ
$15.10
-$0.40 (-2.58%)
Sep 22, 2026, 1:59 PM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.07M | n/a | 512K | n/a | 979K | n/a | n/a | 231K | 776K | n/a | n/a | n/a |
Gross Profit | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -1.07M | n/a | -512K | n/a | -979K | n/a | n/a | -231K | -776K | n/a | n/a | n/a |
Operating Income | -13.78M | -13.31M | -12.6M | -10.73M | -9.65M | -9.31M | -10.27M | -8.29M | -9.05M | -8.42M | -9.94M | -8.93M | -8.17M | -8.64M | -7.99M | -7.36M | -8.01M | -8.78M | -3.94M | -3.63M | -3.48M | -2.74M |
Interest Income | n/a | n/a | n/a | n/a | 944K | 716K | 800K | 1.19M | 1.87M | 444K | 763K | n/a | n/a | n/a | 7.99K | 4.74K | n/a | n/a | 199.38K | n/a | n/a | n/a |
Pretax Income | -45.58M | -22.95M | -12.17M | -11.69M | -10.05M | -8.59M | -9.47M | -6.92M | -7.37M | -7.98M | -7.36M | -4.95M | -8.67M | -8.17M | -3.39M | -2.61M | -1.99M | -25.74M | -3.8M | -4.8M | -6.97M | -11.7M |
Net Income | -45.81M | -22.94M | -12.14M | -11.69M | -10.11M | -8.69M | -9.48M | -6.92M | -7.37M | -7.98M | -7.37M | -4.91M | -8.69M | -8.19M | -3.4M | -2.62M | -2M | -25.74M | -3.78M | -4.8M | -6.98M | -11.71M |
Selling & General & Admin | 3.88M | 2.34M | 3.03M | 2.42M | 2.64M | 2.14M | 2.74M | 2.12M | 2.19M | 1.98M | 2.45M | 2.25M | 2.21M | 2.34M | 2.61M | 2.53M | 2.56M | 3.55M | 714K | 602K | 481K | 546K |
Research & Development | 9.91M | 10.98M | 9.58M | 8.31M | 7.01M | 7.17M | 7.53M | 6.17M | 6.87M | 6.45M | 7.49M | 6.67M | 5.96M | 6.31M | 5.38M | 4.83M | 5.45M | 5.24M | 3.23M | 3.03M | 3M | 2.19M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -1.07M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 13.78M | 13.31M | 12.6M | 10.73M | 9.65M | 9.31M | 10.27M | 8.29M | 9.05M | 8.42M | 8.87M | 8.93M | 8.17M | 8.64M | 7.99M | 7.36M | 8.01M | 8.78M | 3.94M | 3.63M | 3.48M | 2.74M |
Interest Expense | 31.8M | 9.64M | n/a | 2.34M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 7.97M | 4.74M | 6.02M | 16.96M | n/a | 1.17M | 3.49M | 8.97M |
Selling & Marketing Expenses | 311K | 241K | 452K | 490K | 459K | 459K | 687K | 529K | 600K | 533K | 452K | 552K | 520K | 400K | 397K | 248K | 121K | 208K | 126K | 102K | 87K | 167K |
Cost & Expenses | 13.78M | 13.31M | 12.6M | 10.73M | 9.65M | 9.31M | 10.27M | 8.29M | 9.05M | 8.42M | 9.94M | 8.93M | 8.17M | 8.64M | 7.99M | 7.36M | 8.01M | 8.78M | 3.94M | 3.63M | 3.48M | 2.74M |
Income Tax Expense | 229K | -11K | -35K | -8K | 65K | 99K | 2K | n/a | 3K | 1K | 8K | -39K | 26K | 21K | 3K | 9K | 6K | 2K | -14K | -5K | 15K | 11K |
Shares Outstanding (Basic) | 90.95M | 89.71M | 85.67M | 83.75M | 80.35M | 70.45M | 70.09M | 69.9M | 69.87M | 69.71M | 69.67M | 69.47M | 69.32M | 69.21M | 69.11M | 68.8M | 68.43M | 47.5M | 47.5M | 67.62M | 67.62M | 67.62M |
Shares Outstanding (Diluted) | 90.95M | 89.71M | 85.67M | 85.26M | 80.35M | 70.45M | 70.09M | 69.9M | 69.87M | 69.71M | 69.67M | 69.47M | 69.32M | 69.21M | 69.11M | 68.8M | 68.43M | 47.5M | 47.5M | 67.62M | 67.62M | 67.62M |
EPS (Basic) | -0.50 | -0.26 | -0.14 | -0.14 | -0.13 | -0.12 | -0.14 | -0.10 | -0.11 | -0.11 | -0.11 | -0.07 | -0.13 | -0.12 | -0.05 | -0.04 | -0.03 | -0.54 | -0.08 | -0.07 | -0.10 | -0.17 |
EPS (Diluted) | -0.50 | -0.26 | -0.14 | -0.14 | -0.13 | -0.12 | -0.14 | -0.10 | -0.11 | -0.11 | -0.11 | -0.07 | -0.13 | -0.12 | -0.05 | -0.04 | -0.03 | -0.54 | -0.08 | -0.07 | -0.10 | -0.17 |
EBITDA | -13.78M | -13.31M | -11.24M | -11.2M | -9.18M | -9.31M | -5.4M | -8.02M | -8.77M | -8.16M | -8.87M | -8.68M | -8.16M | -8.4M | -7.01M | -7.11M | -7.77M | -8.55M | -3.17M | -3.45M | -3.29M | -2.57M |
EBIT | -13.78M | -13.31M | -12.47M | -11.2M | -9.18M | -9.31M | -5.67M | -8.29M | -9.05M | -8.42M | -9.94M | -8.93M | -8.67M | -8.64M | -7.99M | -7.36M | -8.01M | -8.78M | -3.94M | -3.63M | -3.48M | -2.74M |
Depreciation & Amortization | n/a | n/a | 1.23M | 275.5K | 266.5K | 275.5K | 275.5K | 268.5K | 280K | 268.5K | 1.07M | 244.75K | 512K | 244.75K | 979K | 244K | 244K | 231K | 776K | 189K | 189K | 164K |
Add to Watchlist
Select watchlists to add or remove DRTS